Cargando…

KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation

Hepatocellular cancer (HCC) has been reported to belong to one of the highly vascularized solid tumours accompanied with angiogenesis of human umbilical vein endothelial cells (HUVECs). KDM5A, an attractive drug target, plays a critical role in diverse physiological processes. Thus, this study aims...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yu‐Shui, Wu, Ting‐Miao, Qian, Bin, Liu, Yu‐Shan, Ding, Hua, Fan, Ming‐Ming, Liu, Ji‐Bin, Yu, Fei, Wang, Hui‐Min, Shi, Yi, Gu, Li‐Peng, Li, Liu, Tian, Lin‐Lin, Wang, Pei‐Yao, Wang, Gao‐Ren, Wu, Zhi‐Jun, Zou, Qi‐Fei, Ling, Chang‐Chun, Fu, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051710/ https://www.ncbi.nlm.nih.gov/pubmed/33621431 http://dx.doi.org/10.1111/jcmm.16371

Ejemplares similares

Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2010)

Expression and clinical significance of FXYD3 in endometrial cancer
por: LI, YIFEI, et al.
Publicado: (2014)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)

Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma
por: Wang, Li-Juan, et al.
Publicado: (2018)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2013)

Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression
por: Vallois, David, et al.
Publicado: (2014)

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression
Publicado: (2014)

Extracellular vesicles‐encapsulated let‐7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis
por: Liu, Jiefeng, et al.
Publicado: (2020)

What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021)

KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells
por: Kong, Lingzhi, et al.
Publicado: (2016)

KDM2A Targets PFKFB3 for Ubiquitylation to Inhibit the Proliferation and Angiogenesis of Multiple Myeloma Cells
por: Liu, Xinling, et al.
Publicado: (2021)

FXYD domain containing ion transport regulator 5 (FXYD5) silencing promotes cell viability and alleviates inflammatory response in cerulein-induced AR42J cells by blocking JAK2/STAT3 signaling pathway
por: Ding, Licheng, et al.
Publicado: (2022)

Expression mode and prognostic value of FXYD family members in colon cancer
por: Jin, Ming, et al.
Publicado: (2021)

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport
por: Arystarkhova, Elena, et al.
Publicado: (2017)

FXYD-3 expression in relation to local recurrence of rectal cancer
por: Loftas, Per, et al.
Publicado: (2016)

Irisin Enhances Angiogenesis of Mesenchymal Stem Cells to Promote Cardiac Function in Myocardial Infarction via PI3k/Akt Activation
por: Yang, Fan, et al.
Publicado: (2021)

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
por: Wang, Hongqiang, et al.
Publicado: (2019)

The EP300, KDM5A, KDM6A and KDM6B Chromatin Regulators Cooperate with KLF4 in the Transcriptional Activation of POU5F1
por: Wang, Wan-Ping, et al.
Publicado: (2012)

Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR‐433‐3p/YWHAZ cascade
por: Yang, Chao, et al.
Publicado: (2023)

Displacement of Native FXYD Protein From Na(+)/K(+)-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
por: Liu, Chia-Chi, et al.
Publicado: (2022)

Histone demethylase Kdm5c regulates osteogenesis and bone formation via PI3K/Akt/HIF1α and Wnt/β-catenin signaling pathways
por: Li, Ying, et al.
Publicado: (2023)

FXYD6 is a new biomarker of cholangiocarcinoma
por: CHEN, XIONGFEI, et al.
Publicado: (2014)

lncRNA LINC00460 Silencing Represses EMT in Colon Cancer through Downregulation of ANXA2 via Upregulating miR-433-3p
por: Hong, Weiwen, et al.
Publicado: (2019)

KDM3A and KDM4C Regulate Mesenchymal Stromal Cell Senescence and Bone Aging via Condensin-mediated Heterochromatin Reorganization
por: Huang, Biao, et al.
Publicado: (2019)

Specific Phosphorylation of Histone Demethylase KDM3A Determines Target Gene Expression in Response to Heat Shock
por: Cheng, Mo-bin, et al.
Publicado: (2014)

LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia
por: Zhao, Chenyang, et al.
Publicado: (2022)

Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway
por: YANG, LIAN, et al.
Publicado: (2016)

Effects of Simulated Microgravity on Human Umbilical Vein Endothelial Cell Angiogenesis and Role of the PI3K-Akt-eNOS Signal Pathway
por: Shi, Fei, et al.
Publicado: (2012)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

KDM2B regulates hippocampal morphogenesis by transcriptionally silencing Wnt signaling in neural progenitors
por: Zhang, Bo, et al.
Publicado: (2023)

Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway
por: Chen, Pingping, et al.
Publicado: (2022)

Roxarsone induces angiogenesis via PI3K/Akt signaling
por: Wang, Yujing, et al.
Publicado: (2016)

Interaction of hydroxyapatite nanoparticles with endothelial cells: internalization and inhibition of angiogenesis in vitro through the PI3K/Akt pathway
por: Shi, Xingxing, et al.
Publicado: (2017)

c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial–mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling
por: Xu, X, et al.
Publicado: (2016)

miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma
por: Jin, Yun-Peng, et al.
Publicado: (2018)

MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma
por: Sun, Shupeng, et al.
Publicado: (2016)

miR-21 antagonist alleviates colitis and angiogenesis via the PTEN/PI3K/AKT pathway in colitis mice induced by TNBS
por: Xie, Xiaoran, et al.
Publicado: (2022)

MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK
por: Wang, Yong-Jian, et al.
Publicado: (2017)

Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma
por: Hsu, I-Ling, et al.
Publicado: (2016)

FXYD6 promotes thermal nociception by regulating TRPV1
por: Luo, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jqjen3glhsmt9jrbvgg6uealka